ArticleJournal of managed care & specialty pharmacy2026
Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancer.
Shweta Kamat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.